Plasma ALT, AST, LDL-C, TG, and TC levels were measured enzymatically using the Clinical Analyzer 7180 (Hitachi High-Technologies, Tokyo, Japan)
These medications work by mimicking the action of endogenous GLP-1, binding to GLP-1 receptors found throughout the body, particularly in the pancreas, brain, and gastrointestinal tract
Their European base gives them a compliance advantage for EU market access, and their pipeline includes formulation work around newer molecules like semaglutide
If GI side effects are severe or persistent, your healthcare provider may recommend slowing or pausing dose escalation, or in some cases, reducing the dose temporarily